亿帆医药：亿立舒美国市场的里程碑款包括首付款、上市里程碑款及销售里程碑款

Core Points - Yifan Pharmaceutical (002019) responded to investor inquiries on October 24, detailing the milestone payments for Yilishu in the U.S. market, which include upfront payments, milestone payments upon product launch, and sales milestone payments [1] - The revenue from Yilishu encompasses shipping revenue and sales sharing payments [1]